ECO Animal Health Group (LON:EAH) Given “Buy” Rating at Shore Capital

Shore Capital restated their buy rating on shares of ECO Animal Health Group (LON:EAH) in a report issued on Monday morning, MarketBeat reports. The firm currently has a GBX 150 price objective on the stock.

ECO Animal Health Group Stock Up 3.2%

Shares of LON:EAH opened at GBX 80 on Monday. The business’s 50 day simple moving average is GBX 81.87 and its two-hundred day simple moving average is GBX 69.93. The firm has a market cap of £53.99 million, a P/E ratio of 32.92 and a beta of -0.05. The company has a debt-to-equity ratio of 4.81, a quick ratio of 2.14 and a current ratio of 2.96. ECO Animal Health Group has a 52-week low of GBX 50 and a 52-week high of GBX 100.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.